Swedish mastectomy sufferers denied compensation
This article was originally published in Clinica
Executive Summary
Swedish women who suffered from the effects of extremely high doses of radiation during treatment for breast cancer from 1960-1985 are unlikely to gain compensation from the Swedish government, said health minister Lars Engqvist last week. In reply to a question by Ola Karlsson MP, Mr Engqvist said that, while he regretted that the women had experienced serious negative effects from the radiation, the treatment had been in line with the scientific evidence and experience available at that time. "It is therefore not feasible to talk about taking measures to offer compensation to this group of individuals," he added.
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.